Arche Investment is a new technology finance company founded in August 2017 as a 100% subsidiary of REYON PHARMACEUTICAL Co., Ltd., a KOSPI-listed pharmaceutical manufacturer.
With our parent company’s expertise in pharmaceuticals and bio industry, we invest in companies with rising technology in bio and potentials to change the existing industrial structure to generate profit for the investors.
We will increase investment with pride in the ability to gain profit and help the society based on the principle to invest in the technology that can make our lives safer, more convenient, and more pleasant.
Also, we will not simply make investments, but provide various activities to actually increase the value of our investees, including marketing activities using our network and investees, advice for distinguished management strategies, and active capital procurement activities.
These activities are very helping for the new companies that are solely depending on new technology.
Arche Investment will make ceaseless efforts to return to you with higher profit.
Thank you for your support and we will greatly appreciate your encouragement.